Douglas E. Onsi J.D.
Net Worth

Last updated:

What is Douglas E. Onsi J.D. net worth?

The estimated net worth of Mr. Douglas E. Onsi J.D. is at least $7,087,903 as of 26 Jan 2024. He owns shares worth $165,983 as insider and has received compensation worth at least $6,921,920 in Leap Therapeutics, Inc..

What is the salary of Douglas E. Onsi J.D.?

Mr. Douglas E. Onsi J.D. salary is $865,240 per year as Chief Financial Officer, Gen. Counsel, Treasurer & Sec., Pres, Chief Executive Officer & Director in Leap Therapeutics, Inc..

How old is Douglas E. Onsi J.D.?

Mr. Douglas E. Onsi J.D. is 56 years old, born in 1969.

What stocks does Douglas E. Onsi J.D. currently own?

As insider, Mr. Douglas E. Onsi J.D. owns shares in one company:

Company Title Shares Price per share Total value
Leap Therapeutics, Inc. (LPTX) Chief Financial Officer, Gen. Counsel, Treasurer & Sec., Pres, Chief Executive Officer & Director 592,797 $0.28 $165,983

What does Leap Therapeutics, Inc. do?

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Douglas E. Onsi J.D. insider trading

Leap Therapeutics, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 7,500 N/A N/A
Option
Common Stock 7,500 N/A N/A
Option
Restricted Stock Units 660,606 N/A N/A
Option
Common Stock 660,606 N/A N/A
Purchase
Common Stock 571,428 $1.95 $1,114,285
Purchase
Warrant (Right to Buy) 571,428 $1.95 $1,114,285
Purchase
Common Stock 1,057,769 $6.09 $6,436,524
Purchase
Warrant (Right to Buy) 1,057,769 $6.09 $6,436,524

Leap Therapeutics key executives

Leap Therapeutics, Inc. executives and other stock owners filed with the SEC: